Boulechfar S, Da Silva V, Deybach J C, Nordmann Y, Grandchamp B, de Verneuil H
laboratoire de Génétique Moléculaire, Faculté de Médecine Xavier Bichat, Paris, France.
Hum Genet. 1992 Jan;88(3):320-4. doi: 10.1007/BF00197267.
Congenital erythropoietic porphyria (CEP) or Günther's disease is an inborn error of heme biosynthesis transmitted as an autosomal recessive trait and characterized by a profound deficiency of uroporphyrinogen III synthase (UROIIIS) activity. We have previously described two missense mutations in the UROIIIS gene, confirming that the primary defect responsible for CEP is a structural alteration of this gene. We have extended our work to 5 additional unrelated families. Two new point mutations, a deletion and an insertion have been found in the messenger RNA. Our study shows that a molecular heterogeneity of the mutations exists in Günther's disease. One mutation (C73R), however, appears to be more frequent than the others. Finally, the different normal and mutated proteins have been expressed in Escherichia coli to determine the consequence of the mutations on the enzyme activity.
先天性红细胞生成性卟啉病(CEP)或贡瑟氏病是一种遗传性血红素生物合成障碍疾病,呈常染色体隐性遗传,其特征是尿卟啉原III合酶(UROIIIS)活性严重缺乏。我们之前曾描述过UROIIIS基因中的两个错义突变,证实导致CEP的主要缺陷是该基因的结构改变。我们将研究扩展到另外5个无亲缘关系的家族。在信使RNA中发现了两个新的点突变、一个缺失突变和一个插入突变。我们的研究表明,贡瑟氏病存在突变的分子异质性。然而,有一种突变(C73R)似乎比其他突变更常见。最后,已在大肠杆菌中表达了不同的正常和突变蛋白,以确定这些突变对酶活性的影响。